Animal Assisted Mindfulness Intervention (AAMI) for Patients With Acquired Brain Injury

Acquired Brain Injury Clinical Trial

— AAMI  

Official title:

Effects of an Animal Assisted Mindfulness Intervention for Patients With Acquired Brain Injury: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03729908
• Other study ID #: 2018-00564
• Status: Completed
• Phase: N/A
• Start date: June 1, 2018
• Est. completion date: September 12, 2019

Study information

• Verified date: January 2020
• Source: Swiss Tropical & Public Health Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to investigate the effect of an animal assisted mindfulness intervention (AAMI) on patients with acquired brain injuries on their global severity of psychological distress.

In addition, the effects on the patients' symptoms of depression, anxiety, perceived stress, mood, coping and mindfulness/self-compassion will be assessed.

The study experimental condition consists of 6 weeks of intervention, containing 6 different modules. In every session, an animal will be present.

In the control condition, the same program and same exercises will be used without the presence of or reference to animals. Sessions take place two times a week for 6 weeks (leading up to a total of 12 experimental/control sessions), each lasting for about 60 minutes.

24 participants are planned to be included, 12 patients in each group.

Description:

It was estimated that a total sample of 24 participants (12 patients in each group) would provide enough power to detect a medium effect. Since we had several dropouts, two additional groups (one intervention and one control) were started. This lead to the inclusion of 31 participants with a total sample size of 25 participants finishing the program.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 31
• Est. completion date: September 12, 2019
• Est. primary completion date: September 12, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients of REHAB Basel

• Acquired Brain Injury (ABI); FIM (Functional Independence Measure) cut-off score defined as > 60

• Depressive or/and anxiety symptoms

• Psychological difficulties coping with the actual life situation

• 18 years or older

• Willing to work with therapy animals

• German speaking

• Willingness to participate/informed consent

Exclusion Criteria:

• Communication and articulation is not possible

• Allergy to animals

• Aversion against animals

• Schizophrenic-related comorbidity

• Mobilization to "Therapietiergarten" not possible

Related Conditions & MeSH terms

• Acquired Brain Injury
• Brain Injuries
• Wounds and Injuries

Intervention

Behavioral:
• Animal assisted mindfulness based intervention
A mindfulness based intervention in the presence of an animal
• Anti-stress program
A mindfulness based intervention with no reference to animals

Locations

Country	Name	City	State
Switzerland	REHAB Basel	Basel	BS

Sponsors (4)

Lead Sponsor	Collaborator
Swiss Tropical & Public Health Institute	Rehab Basel, University of Basel, University of Bern

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	General psychological distress	Measured via BSI (Global Severity Index GSI). The Global Severity Index (GSI) is designed to help quantify a patient's severity-of-illness and provides a single composite score for measuring the outcome of a treatment program based on reducing symptom severity. Minimal total score = 0, maximal total score = 212 (higher values represent a worse outcome)	11 weeks
Secondary	Depression	Measured via BDI-FS (Beck Depression Inventory - Fast Screen for Medical Clients, without somatic items). The BDI-FS is a fast screen assessment of depression for medical patients. The minimum score is 0, the maximum score is 21, higher values represent a worse outcome.	11 weeks
Secondary	Perceived Stress	Measured via the PSS-10-D (Perceived Stress Scale - 10). The Perceived Stress Scale was developed to measure the degree to which situations in one's life are appraised as stressful. The minimal total score is 1, the maximal total score is 40. Higher values represent worse outcome.	11 weeks
Secondary	Mindfulness	Measured via the FFA-14 (Freiburger Fragebogen zur Achtsamkeit). Minimum total score is 0, maximum total score is 39. Higher values represent a better outcome.	11 weeks
Secondary	Self-compassion	Measured via SCS-D Kurzversion (Self-compassion scale - Deutsch): Minimum total score is 1, maximum total score is 60, higher values represent a better outcome.	11 weeks
Secondary	Coping	Measured via Brief COPE-G: The Brief COPE (-G, German version) Inventory is a multidimensional coping inventory to assess the different ways in which people respond to stress. It measures problem-focused coping, emotion-focused coping, and dysfunctional coping. Each subscale ranges between 1 and 8 with higher values representing higher scores in the respective coping strategy.	11 weeks
Secondary	Visual Analogue Scale (VAS)	A VAS measuring motivation, emotion, cognition and attitude towards animals. The Visual Analogue Scales (VAS) provide a simple technique for measuring subjective experience and are continuous scales comprised of a horizontal line. Minimum score for each item is 0, maximum score is 160 with higher scores representing better outcomes.	11 weeks
Secondary	Mood	Measured via the MDBF before and after each session: Mehrdimensionaler Befindlichkeitsfragebogen. The "Mehrdimensionaler Befindlichkeitsfragebogen" (MDBF) is a German-language instrument to assess the 3 mood dimensions pleasant-unpleasant, awake-sleepy, calm-restless and includes 24 items. Minimum score is 4, maximum score is 20.	6 weeks